CS
MRK icon

Capital Square’s Merck MRK Stock Holding History

Capital Square’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Buy
13,720
+504
+4% +$59K 0.75% 39
2026
Q1 		$1.48M Buy
13,216
+118
+0.9% +$13.6K 0.68% 39
2025
Q4 		$1.38M Sell
13,098
-40
-0.3% -$3.75K 0.7% 40
2025
Q3 		$1.1M Sell
13,138
-461
-3% -$38K 0.56% 52
2025
Q2 		$1.13M Buy
13,599
+1,905
+16% +$151K 0.6% 50
2025
Q1 		$1.05M Buy
11,694
+513
+5% +$47.9K 0.62% 55
2024
Q4 		$1.07M Buy
11,181
+310
+3% +$32K 0.61% 51
2024
Q3 		$1.23M Buy
10,871
+443
+4% +$52.6K 0.75% 38
2024
Q2 		$1.31M Sell
10,428
-252
-2% -$32.5K 0.85% 38
2024
Q1 		$1.41M Buy
10,680
+1,132
+12% +$140K 0.99% 31
2023
Q4 		$1.04M Buy
9,548
+7
+0.1% +$727 1.18% 31
2023
Q3 		$973K Sell
9,541
-48
-0.5% -$5.17K 1.31% 29
2023
Q2 		$1.11M Buy
9,589
+69
+0.7% +$7.83K 1.02% 34
2023
Q1 		$1.07M Sell
9,520
-116
-1% -$12.5K 0.99% 33
2022
Q4 		$1.07M Buy
9,636
+44
+0.5% +$4.5K 0.97% 32
2022
Q3 		$826K Sell
9,592
-46
-0.5% -$4.11K 0.75% 43
2022
Q2 		$878K Sell
9,638
-146
-1% -$12.9K 0.73% 45
2022
Q1 		$802K Sell
9,784
-51
-0.5% -$4.02K 0.57% 58
2021
Q4 		$775K Sell
9,835
-504
-5% -$40.1K 0.54% 67
2021
Q3 		$841K Sell
10,339
-257
-2% -$19.5K 0.6% 58
2021
Q2 		$809K Sell
10,596
-524
-5% -$39K 0.6% 58
2021
Q1 		$809K Buy
11,120
+3,589
+48% +$265K 0.6% 55
2020
Q4 		$587K Sell
7,531
-40
-0.5% -$3.06K 0.49% 64
2020
Q3 		$599K Buy
7,571
+124
+2% +$9.71K 0.62% 56
2020
Q2 		$549K Sell
7,447
-44
-0.6% -$3.31K 0.59% 60
2020
Q1 		$550K Buy
7,491
+17
+0.2% +$1.34K 0.64% 44
2019
Q4 		$648K Buy
+7,474
New +$614K 0.62% 46

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Square's MRK Position: Q2 2026 in Review

Capital Square increased its Merck (MRK) stake by 3.8% in Q2 2026, buying an estimated $59K and bringing the position to 13,720 shares worth $1.7M. The position accounts for 0.75% of the portfolio, ranked #39.

Capital Square first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Capital Square held 13,720 shares of Merck worth $1.7M as of Q2 2026.
  • Capital Square bought 504 Merck shares in Q2 2026, an estimated $59K.
  • Merck made up 0.75% of Capital Square's portfolio in Q2 2026, its #39 holding.
  • Capital Square first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capital Square's 13F filing for Q2 2026, filed 13 Aug 2026.